Growth Factors

Papers
(The TQCC of Growth Factors is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An appraisal of vascular endothelial growth factor (VEGF): the dynamic molecule of wound healing and its current clinical applications20
Transforming growth factor-β signalling pathway in tendon healing14
Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients14
The roles of epidermal growth factor receptor in viral infections8
Regenerative responses of rabbit corneal endothelial cells to stimulation by fibroblast growth factor 1 (FGF1) derivatives, TTHX1001 and TTHX11148
Role of the BMP6 protein in breast cancer and other types of cancer7
Myokine-mediated exercise effects: the role of myokine meteorin-like hormone (Metrnl)7
Effects of galectin-1 on immunomodulatory properties of human monocyte-derived dendritic cells6
Platelet lysate and tendon healing: comparative analysis of autologous frozen-thawed PRP and ketorolac tromethamine in the treatment of patients with rotator cuff tendinopathy5
The cellular and molecular mediators of metastasis to the lung5
Third-degree burn mouse treatment using recombinant human fibroblast growth factor 25
Comparative evaluation of autologous platelet-rich plasma and platelet lysate in patients with knee osteoarthritis5
Matrine induces hepatocellular carcinoma apoptosis and represses EMT and stemness through microRNA-299-3p/PGAM1 axis5
Evaluation of the effect of injectable platelet-rich fibrin (i-PRF) in wound healing and growth factor release in rats: a split-mouth study4
High mobility group box 1 and Dickkopf-related protein 1 as biomarkers of glucose toxicity, atherogenicity, and lower β cell function in patients with type 2 diabetes mellitus4
Autologous conditioned serum for degenerative diseases and prospects3
Fibroblast growth factor 23 and its role in bone diseases3
Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial–mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression3
0.018213987350464